Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project-Reference-Cited by-同舟云学术

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

Published:2018-11-23 Issue:12 Volume:8 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Usmani Saad Z.,Hoering Antje,Cavo Michele,Miguel Jesus San,Goldschimdt Hartmut,Hajek Roman,Turesson Ingemar,Lahuerta Juan Jose,Attal Michel,Barlogie Bart,Lee Jae Hoon,Kumar Shaji^ORCID,Lenhoff Stig,Morgan Gareth,Rajkumar S. Vincent^ORCID,Durie Brian G. M.,Moreau Philippe

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-018-0155-7.pdf

Reference20 articles.

1. Palumbo, A. et al. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood 112, 3107–3114 (2008).

2. Palumbo, A. et al. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA–Italian Multiple Myeloma Network. J. Clin. Oncol. 25, 4459–4465 (2007).

3. San Miguel, J. F. et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N. Engl. J. Med. 359, 906–917 (2008).

4. Mateos, M. V. et al. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomized trial. Lancet Oncol. 11, 934–941 (2010).

5. Usmani, S. Z. et al. Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured? Leukemia 27, 226–232 (2013).

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients;Journal of Clinical Laboratory Analysis;2024-09-12

2. PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells;The FASEB Journal;2024-08-27

3. Multiple myeloma complicated with light chain cast nephropathy with focal amyloidosis: A case report;Nephrology;2024-05-14

4. Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials;Cancers;2023-12-08

5. Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-11